US$1.42-20.5%11月13日 收盘
The latest quarter (ended 2026年9月30日) is from Tenon Medical’s earnings press release of 2026年11月12日. It will be replaced by the official quarterly report (10-Q) once Tenon Medical files it.
| 指标 | 截至该日的 3 个月2026年9月30日 | 截至该日的 3 个月2025年9月30日 | 变动 |
|---|---|---|---|
| 营业收入合计 | US$1.4M | US$1.2M | +22.08% |
这些是单季度数字，不是滚动一年——本站其他地方的数字覆盖十二个月，会大得多。季节性业务在两者之间摆动很大：ServiceNow 在十二月季度赚 20 亿美元自由现金流，在六月季度只有 5 亿。
对比对象是去年同一季度，而不是分析师预测。要说“超预期”或“不及预期”需要一致预期数据，那是我们没有的授权数据——而搞错它比不提更糟。
“Third quarter revenue of $1.4 million grew 22% compared to the prior year and 12% sequentially from the second quarter, and we delivered that growth while reducing operating expenses compared to both the third quarter of 2025 and the second quarter of this year,”
逐字引自公告，且只在文件将其归于具名人士时才展示。
公告在开盘前或收盘后发布，因此区间从公告日前一个交易日的收盘价到公告日之后那个交易日的收盘价——无论哪种情况，反应都包含在内。
Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the “SI Joint”). The Company has developed The Catamaran ® SI Joint Fusion System (“The Catamaran System”) that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially all the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+ ® SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon has been focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.
公司自己的描述，取自公告末尾。
The quote, the company description and the latest quarter come from Tenon Medical’s earnings press release (an Item 2.02 8-K) filed 2026年11月12日. Earlier quarters come from its quarterly and annual reports, and the latest will be replaced once the official report is filed. 在 EDGAR 上阅读公告 股价已按拆股和分红复权。
Tenon Medical, Inc reported on 2026年11月12日. We are fetching the call transcript; its summary follows once the transcript is in.
Just reported
From Tenon Medical, Inc's results release of 2026年11月12日. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Actual
US$1.4M
+22% y/y
+12% q/q
Guided
—
No guide given
Actual
-US$3.1M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.